Prevalence and Effect Factors of HBV among Injection Drug Users in Kermanshah, Iran in 2016

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Gheibipour H.; ETEMAD K.; KHODAKARIM S.; Sharhani A.; Ebrahimi Kebria S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Epidemiology Year:2019 | Volume:15 | Issue:1 Page(s): 40-46

Download Full-Text

Persian Verion

View:

363

Download:

Cites:

Information Journal Paper

Title

Prevalence and Effect Factors of HBV among Injection Drug Users in Kermanshah, Iran in 2016

Author(s)

Keywords

Hepatitis BQ3

PrevalenceQ3

Risk factorQ2

Drug injectionQ1

KermanshahQ2

Abstract

Background and Objectives: The Prevalence of HBV infection among injection drug users (IDUs) is higher than the general population due to high-risk sexual behaviors and the needle sharing. The aim of this study was to determine the Prevalence of HBV infection and its effective factors among IDUs of Kermanshah Province in 2016. Methods: This ia descriptive-analytic study was performed in 606 male IDUs in Kermanshah Province in 2016. Data were collected through questionnaires and interviews. HBV was also evaluated through blood tests using the rapid test. Simple and multivariate logistic regression analyses were applied to investigate the factors affecting HBV infection. Data were analyzed using STATA-12 software. Results: The Prevalence of positivity HBV antibody was 3% (95% CI: 1. 61-4. 32) among male IDUs. According to the results of unit-variable logistic regression analysis, the duration of Drug injection (OR = 1. 08, 95% CI: 1. 02-1. 15) and the number of daily injections (OR = 1. 38, 95% CI: 1. 05-1. 81) were Risk factors for HBsAg positivity but there were no significant associations in the multivariate regression model. Conclusion: The Prevalence of HBV is much higher among IDUs than in the general population. These populations are at risk for viral infections such as HBV; therefore, it is recommended to provide necessary education about the prevention methods as well as the necessary screening for them.

Cites

No record.

References

No record.

Cite

APA: Copy

Gheibipour, H., ETEMAD, K., KHODAKARIM, S., Sharhani, A., & Ebrahimi Kebria, S.. (2019). Prevalence and Effect Factors of HBV among Injection Drug Users in Kermanshah, Iran in 2016. IRANIAN JOURNAL OF EPIDEMIOLOGY, 15(1 ), 40-46. SID. https://sid.ir/paper/376208/en

Vancouver: Copy

Gheibipour H., ETEMAD K., KHODAKARIM S., Sharhani A., Ebrahimi Kebria S.. Prevalence and Effect Factors of HBV among Injection Drug Users in Kermanshah, Iran in 2016. IRANIAN JOURNAL OF EPIDEMIOLOGY[Internet]. 2019;15(1 ):40-46. Available from: https://sid.ir/paper/376208/en

IEEE: Copy

H. Gheibipour, K. ETEMAD, S. KHODAKARIM, A. Sharhani, and S. Ebrahimi Kebria, “Prevalence and Effect Factors of HBV among Injection Drug Users in Kermanshah, Iran in 2016,” IRANIAN JOURNAL OF EPIDEMIOLOGY, vol. 15, no. 1 , pp. 40–46, 2019, [Online]. Available: https://sid.ir/paper/376208/en

Related Journal Papers